Status:

COMPLETED

Clarithromycin in Active Crohn's Disease

Lead Sponsor:

Royal Liverpool University Hospital

Collaborating Sponsors:

Abbott

Conditions:

Crohn's Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Clarithromycin may be an effective therapy in Crohn's disease. It is a broad spectrum antibiotic. Crohn's disease, the investigators think, is in some way related to bacteria, which reside in the bowe...

Detailed Description

WHAT IS THE PROBLEM TO BE ADDRESSED ? Lack of effective cure for Crohn's disease. Effective symptomatic treatment of Crohn's disease can be achieved in approximately 60-80% using corticosteroids \[1...

Eligibility Criteria

Inclusion

  • Patients with Crohn's disease diagnosed by conventional clinical, radiological and histological criteria.
  • Active Crohn's disease: Crohn's Disease Activity Index (CDAI)\> 200 and CRP \> 10 mg/l.
  • Patients on 10mg or less of prednisolone or 3mg budesonide.
  • Patients on a stable dose of azathioprine for at least 3 months and on stable dose of 5-ASA preparation for at least one month.

Exclusion

  • Patients under 18 or unable to give informed consent.
  • Patients on long term antibiotics for Crohn's disease or other indications
  • Known sensitivity to clarithromycin
  • Pregnant, post partum (\<3months) or breast feeding females.
  • Any change to medication for Crohn's disease for previous month.
  • Patients with complications requiring surgery (significant intestinal obstruction, perforation or abscess)
  • CDAI \> 450
  • Participation in other trials in the last 3 months.
  • Serious intercurrent infection or other clinically important active disease (including renal and hepatic disease)
  • Patients on cisapride, astemizole or terfenadine (prolonged QT interval and arrhythmias reported with macrolide antibiotics)

Key Trial Info

Start Date :

April 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT00269386

Start Date

April 1 2000

End Date

May 1 2007

Last Update

January 7 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Liverpool University Hospital

Liverpool, Merseyside, United Kingdom, L7 8XP